Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression
about
NF90 in posttranscriptional gene regulation and microRNA biogenesisSuppression of MicroRNA-7 (miR-7) Biogenesis by Nuclear Factor 90-Nuclear Factor 45 Complex (NF90-NF45) Controls Cell Proliferation in Hepatocellular CarcinomaOverexpression of NF90-NF45 Represses Myogenic MicroRNA Biogenesis, Resulting in Development of Skeletal Muscle Atrophy and Centronuclear Muscle FibersNovel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: Implications for the HTLV lifecyclesHOXC8 promotes breast tumorigenesis by transcriptionally facilitating cadherin-11 expression.SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cellsTerminalia catappa attenuates urokinase-type plasminogen activator expression through Erk pathways in Hepatocellular carcinoma.Association of genetic variants with dyslipidemia and chronic kidney disease in a longitudinal population-based genetic epidemiological studySerum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model.Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression.Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways.Triple negative breast cancer development can be selectively suppressed by sustaining an elevated level of cellular cyclic AMP through simultaneously blocking its efflux and decomposition.Ilf3 and NF90 functions in RNA biology.Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis.α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway.Expression and Clinical Significance of ILF2 in Gastric Cancer.TGFβ1 Promotes Gemcitabine Resistance through Regulating the LncRNA-LET/NF90/miR-145 Signaling Axis in Bladder Cancer.Sp5 induces the expression of Nanog to maintain mouse embryonic stem cell self-renewal.Interleukin enhancer-binding factor 3 and HOXC8 co-activate cadherin 11 transcription to promote breast cancer cells proliferation and migration.Long non-coding RNAs in metastasis.Nuclear factor 90 promotes angiogenesis by regulating HIF-1α/VEGF-A expression through the PI3K/Akt signaling pathway in human cervical cancer.Tissue-Specific Signaling Networks Rewired by Major Somatic Mutations in Human Cancer Revealed by Proteome-Wide Discovery.Interleukin enhancer binding factor 2 is a prognostic biomarker for breast cancer that also predicts neoadjuvant chemotherapy responses.
P2860
Q28388023-FB4BF5EE-D8F0-4178-AF91-ECDDF20A823CQ28392330-FAD859A9-6A6D-4C60-9CD4-D5B7108562BAQ28395692-654DC5E8-A69B-4BF2-969A-4CF94D434311Q28397941-7DF86C97-52D9-4F7A-8A78-F333542FE7F4Q33757052-DD722854-BBD0-47C3-844F-687976677811Q33891236-4FF69C83-B35D-4A3C-8E9C-9710D7D36803Q35179582-B8BD35AC-6EAB-47DD-BE14-434A07C05281Q35234535-CCCB92E0-BCAE-455D-9F9F-5F6C6D23A9A0Q35990029-CEF77FC1-16DC-4148-9A25-A2CD67AE87E3Q36356167-A7629443-BA12-4701-A653-5F2DBB0436CDQ37694339-56FECEEA-DD37-4782-BE87-D7C63BE6B504Q37699405-76915E74-E140-4698-A253-70B1A9D71BD7Q38261272-5E2C102C-C518-4415-9422-8599442118A9Q38865528-C7113A8B-E3B5-49DD-B204-0FB5963194FAQ41098517-22BE1204-3462-4608-A41F-7592EEA2AA6BQ41376426-2ED49FF0-1B6E-4727-B63D-0490CC824620Q41481557-FC87F841-F6DC-45F4-806F-8C1393BB444DQ42367549-035324E1-90ED-4C6F-A6BB-CBFCA1D798C2Q47116433-A6FF73C3-3882-42B8-91F3-D42E20F4CC53Q49914094-75FD40FF-FF07-45BB-AF88-08E7774538CCQ49959117-B2F1941F-0068-46BD-B5D9-206835849439Q51079339-8C2D1802-B85F-4E3F-86A7-380C00DC68A9Q55711788-7C6F3603-1273-4E40-91B6-617088D96370
P2860
Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Interleukin enhancer-binding f ...... asminogen activator expression
@ast
Interleukin enhancer-binding f ...... asminogen activator expression
@en
Interleukin enhancer-binding f ...... asminogen activator expression
@nl
type
label
Interleukin enhancer-binding f ...... asminogen activator expression
@ast
Interleukin enhancer-binding f ...... asminogen activator expression
@en
Interleukin enhancer-binding f ...... asminogen activator expression
@nl
prefLabel
Interleukin enhancer-binding f ...... asminogen activator expression
@ast
Interleukin enhancer-binding f ...... asminogen activator expression
@en
Interleukin enhancer-binding f ...... asminogen activator expression
@nl
P2093
P2860
P3181
P356
P1433
P1476
Interleukin enhancer-binding f ...... asminogen activator expression
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/ONC.2012.414
P407
P577
2013-08-22T00:00:00Z
P5875
P6179
1050652221